SUBSCRIBE
SUBSCRIBE

Humanetics

IN THE PRESS
Business
ONL Therapeutics Appoints Sushanta Mallick as Chief Development Officer
February 9, 2022
 · 
4 min read
BioMidwest
ONL Therapeutics Closes 2nd Tranche of $46.9 Million Series B Financing Upon Achieving ONL1204 Development Milestones
January 13, 2022
 · 
3 min read
Business
Humanetics Corporation Adds Two New Experts to its Board
October 26, 2021
 · 
3 min read
Drug Development
Humanetics Corporation Announces Results from Phase 1 Trial of BIO 300 Oral Powder
September 22, 2021
 · 
3 min read
FDA
Humanetics Corporation’s BIO 300 Receives Fast Track Designation from FDA
August 24, 2021
 · 
2 min read
BioMidwest
Humanetics Corporation Receives Funding From Regenerative Medicine Minnesota to Study New Drug for Triple Negative Breast Cancer
June 2, 2021
 · 
3 min read
Deals
Humanetics Corporation Receives Funding From Department of Defense to Test Drug Against COVID-19
January 26, 2021
 · 
3 min read
Business
ONL Therapeutics Names Connie Chang as Chief Operating OfficerCompany expands leadership team as it advances lead candidate ONL1204 beyond retinal detachment into the chronic conditions of glaucoma and dry age-related macular degeneration
January 19, 2021
 · 
3 min read
BioMidwest
ONL Therapeutics Closes $46.9 Million in Series B Financing to Advance ONL1204 into Three Retinal Disease Indications
December 22, 2020
 · 
4 min read
Business
Amit Singhi joins Humanetics Group as Chief Financial Officer (CFO)
December 1, 2020
 · 
3 min read
Load More
JOBS